Chargement en cours...
Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
INTRODUCTION: Aspirin may reduce the risk of chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC) in patients receiving antiviral treatment. We aimed to investigate the impact of aspirin on reducing HCC risk in patients treated with first-line oral nucleos(t)ide analogs (NAs; entecavir a...
Enregistré dans:
| Publié dans: | Clin Transl Gastroenterol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8126482/ https://ncbi.nlm.nih.gov/pubmed/33750746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000324 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|